Analyst firms · H.C. Wainwright · LTRN

H.C. Wainwright LTRN price target and rating history

Lantern Pharma Inc. (LTRN) · Health Care

H.C. Wainwright rates Lantern Pharma Inc. (LTRN) Buy with a $36 price target, as of its latest action on Mar 11, 2022. It has published 3 rating actions on LTRN since October 2021, including 0 upgrades and 0 downgrades.

Current rating
Buy
Price target
$36
Median target, all firms
Too few
Actions on LTRN
3

H.C. Wainwright price target on LTRN

$36$34$3220222023202420252026
H.C. Wainwright price target on LTRN, each point a stated target, October 2021 to March 2022.

Every H.C. Wainwright rating on LTRN

Questions about H.C. Wainwright and LTRN

What is H.C. Wainwright's price target for LTRN?
H.C. Wainwright's latest stated price target for Lantern Pharma Inc. (LTRN) is $36, from its action on Mar 11, 2022.
What is H.C. Wainwright's rating on LTRN?
H.C. Wainwright rates LTRN Buy, a bullish rating, as of Mar 11, 2022.
When did H.C. Wainwright last change its view on LTRN?
On Mar 11, 2022, H.C. Wainwright raises its price target to $36 from $34, keeps Buy.

All H.C. Wainwright ratingsLTRN news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.